Work

Phase I Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study (ADVL0015)

Year: 2004

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.12.185

Authors: Susan M. Blaney, Mark Bernstein, Kathleen Neville, Jill Ginsberg, Brenda Kitchen, Terzah Horton, Stacey L. Berg, Mark Krailo, Peter C. Adamson

Institutions: Children's Hospital of Philadelphia, Baylor College of Medicine, Rainbow Babies & Children's Hospital

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources

Awards: G1117719904, G3755601767, General Clinical Research Center

OpenAlex ID: W2170220752

FWCI: 4.144

Cites: 18

Cited by: 117

Related to: 10